The storied success of sildenafil has undeniably shaped the pharmaceutical landscape. However, investing in companies heavily focused on copycat drugs and the declining patent protection surrounding this https://tinybookmarks.com/story21352696/the-blue-pill-and-pharma-a-risky-opportunity